161 related articles for article (PubMed ID: 34145845)
1. [Effectiveness of different screening strategies for cardiovascular diseases prevention in a community-based Chinese population: A decision-analytic Markov model].
Liu QP; Chen XJ; Wang JM; Liu XF; Si YQ; Liang JY; Shen P; Lin HB; Tang X; Gao P
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):460-466. PubMed ID: 34145845
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of statin treatment strategies for primary prevention of cardiovascular diseases in a community-based Chinese population: A decision-analytic Markov model].
Gong C; Liu QP; Wang JM; Liu XF; Zhang ML; Yang H; Shen P; Lin HB; Tang X; Gao P
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):443-449. PubMed ID: 35701120
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of different screening strategies for type 2 diabete on preventing cardiovascular diseases in a community-based Chinese population using a decision-analytic Markov model].
Wang JM; Liu QP; Zhang ML; Gong C; Liu SD; Chen WY; Shen P; Lin HB; Gao P; Tang X
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):450-457. PubMed ID: 35701121
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of aspirin treatment strategies for primary prevention of cardiovascular diseases: A decision-analytic Markov modelling study].
Zhang ML; Liu QP; Gong C; Wang JM; Zhou TJ; Liu XF; Shen P; Lin HB; Tang X; Gao P
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):480-487. PubMed ID: 37291924
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.
Guzauskas GF; Garbett S; Zhou Z; Schildcrout JS; Graves JA; Williams MS; Hao J; Jones LK; Spencer SJ; Jiang S; Veenstra DL; Peterson JF
Ann Intern Med; 2023 May; 176(5):585-595. PubMed ID: 37155986
[TBL] [Abstract][Full Text] [Related]
8. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
[TBL] [Abstract][Full Text] [Related]
9. Impact of China's Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease.
Wang M; Liu J; Bellows BK; Qi Y; Sun J; Liu J; Moran AE; Zhao D
Glob Heart; 2020 Jun; 15(1):43. PubMed ID: 32923337
[TBL] [Abstract][Full Text] [Related]
10. High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis.
Hur C; Choi SE; Kong CY; Wang GQ; Xu H; Polydorides AD; Xue LY; Perzan KE; Tramontano AC; Richards-Kortum RR; Anandasabapathy S
World J Gastroenterol; 2015 May; 21(18):5513-23. PubMed ID: 25987774
[TBL] [Abstract][Full Text] [Related]
11. Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease.
Jiang Y; Ni W
Pharmacoeconomics; 2019 Jul; 37(7):943-952. PubMed ID: 30875022
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
[TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
[No Abstract] [Full Text] [Related]
14. Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam.
Nguyen TP; Wright EP; Nguyen TT; Schuiling-Veninga CC; Bijlsma MJ; Nguyen TB; Postma MJ
PLoS One; 2016; 11(5):e0155699. PubMed ID: 27192051
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
16. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of implementing risk-based cardiovascular disease (CVD) management using updated WHO CVD risk prediction charts in India.
Sivanantham P; S MK; Essakky S; Singh M; Ghosh S; Mehndiratta A; Kar SS
PLoS One; 2023; 18(8):e0285542. PubMed ID: 37624838
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes.
Li T; Wan X; Ma J; Wu B
Adv Ther; 2018 Dec; 35(12):2214-2223. PubMed ID: 30390239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
